Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/02/2003WO2003080037A2 Use of ltb4 antagonists in veterinary medicine
10/02/2003WO2003080029A1 No-donating nsaids adsorbed into carrier particles
10/02/2003WO2003080027A1 Nanoparticulate compositions of angiogenesis inhibitors
10/02/2003WO2003080024A2 Nanoparticulate compositions of map kinase inhibitors
10/02/2003WO2003080022A2 Analgesics for nasal administration
10/02/2003WO2003080021A2 Formulation comprising buprenorphine
10/02/2003WO2003079993A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
10/02/2003WO2003079991A2 Method for administration of growth hormone via pulmonary delivery
10/02/2003WO2003079987A2 A non-selective cation channel in neural cells and methods for treating brain swelling
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003079970A2 4-(diarylmethyl)-1-piperazinyl derivatives
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003051370A8 Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction
10/02/2003WO2003028692A3 Acne treatment using oleanolic acid
10/02/2003WO2003018022A8 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
10/02/2003WO2003016316A8 Diazacycloalkanes as oxytocin agonists
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2003006604A3 Cyclic peptides as potent and selective melanocortin-4 receptor agonists
10/02/2003WO2002099056A3 C22c7orfs as modifiers of the p53 pathway and methods of use
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002085405A3 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF$g(a)
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002069944A3 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
10/02/2003WO2002057474A3 Processes for enhanced production of pantothenate
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003WO2002030940A3 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002020570A3 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening
10/02/2003WO2002018404A9 Nucleoside derivatives for the treatment of hepatitis c
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003WO2002000243A3 Stabilized interleukin 2
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003US20030187302 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1H-naphthalene-2 -one oxime
10/02/2003US20030187289 A biphenyl-alkyloxy-benzoylamino-propionic acid or amide derivatives; treating thrombosis, cardiovascular disorders, arteriosclerosis, inflammation, tumor, osteoporosis, angioplasty aftertreatment
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187268 Imidazole derivatives
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/02/2003US20030187260 Thienopyrimidines
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187256 Benoxazinones/benzothiazinones as serine protease inhibitors
10/02/2003US20030187255 Therapeutic heterocycles
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187225 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187052 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
10/02/2003US20030187050 Crystal structure; stability; bioavailability
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187038 Fibrinogen-lowering agents
10/02/2003US20030187037 Cardiovascular disorders; antiinflammatory agents; antitumor agents
10/02/2003US20030187035 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/02/2003US20030187034 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof
10/02/2003US20030187028 Synergistic mixtures; side effect reduction
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187014 Condensed pyrazole derivatives, process for producing the same and use thereof
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030187002 Antiproliferative agents; anticancer agents
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186994 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186990 Prodrugs of hiv replication inhibiting pyrimidines
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186988 Lymphocyte disease; autoimmune disease
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186985 Oxyiminoalkanoic acid derivatives
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003US20030186983 C-5 Modified indazolylpyrrolotriazines
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186977 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186971 Using 1,3-benothiazine compound
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186960 Nervous system regeneration
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186952 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186946 Suppression of cytotoxic protein conformers
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003US20030186936 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
10/02/2003US20030186926 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
10/02/2003US20030186925 Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
10/02/2003US20030186906 Mixture comprising an inhibitor or suppresor of a gene and a molecule binding to an expression product of that gene
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186900 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases
10/02/2003US20030186877 Helical peptidomimetics
10/02/2003US20030186870 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
10/02/2003US20030186865 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
10/02/2003US20030186844 Gherlin analogs
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
1 ... 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 ... 1564